Australia Patent: Regeneron Pharmaceuticals Files Application for 'CRISPR and AAV strategies for X-linked juvenile retinoschisis therapy'

  • Yang Liu

Press/Media

Period22 Apr 2022

Media coverage

1

Media coverage

  • TitleAustralia Patent: Regeneron Pharmaceuticals Files Application for 'CRISPR and AAV strategies for X-linked juvenile retinoschisis therapy'
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date22/04/22
    PersonsYang Liu
View all 1
View less